Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma
NCT02424045
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
T-cell Lymphoma
Interventions
DRUG:
BCD chemotherapy (Bendamustine, Carboplatin, Dexamethasone)
Sponsor
Samsung Medical Center